HomeCompareAIKI vs PLD

AIKI vs PLD: Dividend Comparison 2026

AIKI yields 56.18% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $5.96M in total portfolio value· pulled ahead in Year 8
10 years
AIKI
AIKI
● Live price
56.18%
Share price
$3.56
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$539.3K
Annual income
$119,796.88
Full AIKI calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — AIKI vs PLD

📍 PLD pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAIKIPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AIKI + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AIKI pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AIKI
Annual income on $10K today (after 15% tax)
$4,775.28/yr
After 10yr DRIP, annual income (after tax)
$101,827.35/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, PLD beats the other by $4,366,143.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AIKI + PLD for your $10,000?

AIKI: 50%PLD: 50%
100% PLD50/50100% AIKI
Portfolio after 10yr
$3.52M
Annual income
$2,688,116.53/yr
Blended yield
76.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

AIKI
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
0.9
Piotroski
6/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AIKI buys
0
PLD buys
0
No recent congressional trades found for AIKI or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAIKIPLD
Forward yield56.18%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$539.3K$6.50M
Annual income after 10y$119,796.88$5,256,436.18
Total dividends collected$441.4K$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: AIKI vs PLD ($10,000, DRIP)

YearAIKI PortfolioAIKI Income/yrPLD PortfolioPLD Income/yrGap
1$16,318$5,617.98$11,255$555.24+$5.1KAIKI
2$26,028$8,567.67$13,062$1,018.59+$13.0KAIKI
3$40,622$12,771.79$15,903$1,926.67+$24.7KAIKI
4$62,094$18,628.85$20,839$3,823.32+$41.3KAIKI
5$93,054$26,613.05$30,464$8,166.08+$62.6KAIKI
6$136,840$37,273.01$52,054$19,457.30+$84.8KAIKI
7$197,645$51,226.14$109,886$54,188.93+$87.8KAIKI
8← crossover$280,629$69,148.09$304,030$186,451.18$23.4KPLD
9$392,030$91,757.54$1,166,125$840,813.32$774.1KPLD
10$539,269$119,796.88$6,504,190$5,256,436.18$5.96MPLD

AIKI vs PLD: Complete Analysis 2026

AIKIStock

AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.

Full AIKI Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this AIKI vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AIKI vs SCHDAIKI vs JEPIAIKI vs OAIKI vs KOAIKI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.